Skip to main content Accessibility help


  • Venkata N. Koka (a1), Morbize Julieron (a1), Jean Bourhis (a1), Francois Janot (a1), Anne Marie Le Ridant (a1), Patrick Marandas (a1), Bernard Luboinski (a1) and Guy Schwaab (a1)...


Forty patients were treated or followed up for aesthesioneuroblastoma between 1980 and 1995 at Institut Gustave Roussy, France. There were three T1; seven T2, 15 T3 and 15 T4 lesions. The cervical metastatic rate at presentation was 18 per cent. Distant metastases were detected by bone marrow biopsy and bone scan in three patients at presentation. Treatment modalities included surgery alone in eight patients, radiotherapy alone in three patients, combined modality surgery plus radiotherapy in 11 patients, chemotherapy alone in two patients, chemotherapy plus radiotherapy in 10 patients, and multimodality therapy chemotherapy plus surgery plus radiotherapy in six patients.

The five-year survival rate was 51 per cent. Multimodality treatment offered better survival (63 per cent at five years) and disease-free interval (54 months). Overall local, regional, and distant failure rates were 58 per cent, 15 per cent and 40 per cent respectively. Distant metastases commonly occurred in bone (82 per cent). Cervical metastasis was an unfavourable prognostic indicator (0 per cent survival at two years).

In conclusion, aesthesioneuroblastoma is sensitive to chemotherapy and radiotherapy. Multimodality therapy should be used initially.


Corresponding author

Address for correspondence: Dr Guy Schwaab, M.D., Chief of Unit-Head and Neck Surgery, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France. Fax: 331 42115273


Hide All
Al Ahwal, M., Jha, N., Nabholtz, J. M., Hugh, J., Birchall, J., Nguyen, G. K. (1993) Olfactory neuroblastoma: report of a case associated with inappropriate antidiuretic hormone secretion. Journal of Otolaryngology 23: 437439.
Arnesen, M. A., Scheithauer, B. W., Freeman, S. (1994) Cushing syndrome secondary to olfactory neuroblastoma. Ultrastructural Pathology 18: 6168.
Bailey, B. J., Barton, S. (1975) Olfactory neuroblastoma: Management and prognosis. Archives of Otolaryngology 101: 15.
Beitler, J. J., Fass, D. E., Brenner, H. A., Huvos, A., Harrison, L. B., Leibel, S. A., Fukus, Z. (1991) Esthesioneuroblas-toma: is there a role for elective neck treatment. Head and Neck 13: 321326.
Berger, L., Luc, R. (1924) Esthesioneuroepithelioma olfactif. Bulletin de I'Association Francaise pour I'Etude du Cancer 13: 410421.
Davis, R. E., Weisser, M. C. (1992) Esthesioneuroblastoma and neck metastases. Head and Neck 14: 477482.
Eden, B. V., Debo, R. F., Larner, J. M., Kelly, M. D., Levine, P. A., Stewart, F. M., Cantrell, R. W., Constable, W. C. (1994) Esthesioneuroblastoma. Long term outcome and patterns of failure. The University of Virginia Experience. Cancer 73: 25562562.
Foote, R. L., Morita, A., Ebersold, M. J., Oslen, K. D., Lewis, J. E., Quast, L. M., Ferguson, J. A., O'Fallon, W. M. (1993) Esthesioneuroblastoma: the role of adjuvant radiation therapy. International Journal of Radiation Oncology Biology and Physics 27: 835842.
Jekunen, A. P., Kairemo, K. J. A., Lehtonen, H. P., Kajanti, M. J. (1996) Treatment of olfactory neuroblastoma. A report of 11 cases. American Journal of Clinical Oncology 19: 7578.
Kadish, S., Goodman, M., Wang, C. C. (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37: 15711576.
Kaplan, E. L., Meijer, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53: 457481.
Levine, P. A., McClean, C., Cantrell, R. W. (1986) Esthesio-neuroblastoma: The University of Virginia Experience 1960–1985. Laryngoscope 96: 742746.
Mills, S. E., Frierson, H. F. (1985) Olfactory neuroblastoma – a clinicopathologic study of cases. American Journal of Surgical Pathology 9: 317327.
Oslen, K. D., DeSanto, L. W. (1983) Olfactory neuroblastoma: biologic and clinical behavior. Archives of Otolaryngology 109: 797802.
Peto, R., Pike, M. C. (1973) Conservatism in the approximation ∑(O-E)2/E in the log-rank test for survival data or tumor incidence data. Biometrics 29: 579584.
Schenck, L., Ogura, J. H. (1972) Esthesioneuroblastoma: an enigma in diagnosis, a dilemma in treatment. Archives of Otolaryngology 96: 322324.
Schwaab, G., Micheau, C., Pacheco, L., Marandas, P., Domenge, C., Richard, J. M., Wibault, P. (1988) Olfactory esthesioneuroblastoma: a report of 40 cases. Laryngoscope 98: 872876.



  • Venkata N. Koka (a1), Morbize Julieron (a1), Jean Bourhis (a1), Francois Janot (a1), Anne Marie Le Ridant (a1), Patrick Marandas (a1), Bernard Luboinski (a1) and Guy Schwaab (a1)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed